Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Joint tobacco smoking and alcohol intake exacerbates cancer risk in women- the Danish nurse cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. An investigation of main meal preferences in nursing home residents

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Hans Erik Johnsen
  • Tobias W Klausen
  • Martin Boegsted
  • Stig Lenhoff
  • Peter Gimsing
  • Ilse Christiansen
  • Tobias Gedde-Dahl
  • Roald Lindås
  • Ulf-Henrik Mellqvist
  • Nordic Myeloma Study Group
View graph of relations
An unexplained survival difference was observed in the Nordic Myeloma Study Group (NMSG) high-dose therapy trial 5/94 in Denmark compared with Sweden and Norway; however, this difference was eliminated in the subsequent NMSG trial 7/98. It was hypothesized that a detailed analysis of potential explanations would reveal important information for future designs of clinical trials for multiple myeloma (MM) patients in Denmark.
Original languageEnglish
JournalClinical Lymphoma & Myeloma
Volume10
Issue number4
Pages (from-to)290-6
Number of pages7
ISSN1557-9190
DOIs
Publication statusPublished - 1 Aug 2010

ID: 32236227